Fubotv earnings beat by $0.10, revenue topped estimates
Atlassian Corp (NASDAQ:TEAM) CEO Michael Cannon-Brookes sold a total of 7,665 shares of Class A Common Stock on August 5, 2025, for approximately $1.4 million. The software company, currently valued at $48.6 billion, maintains impressive gross profit margins of 82% and has achieved 19% revenue growth over the last twelve months, according to InvestingPro data. The sales were executed in multiple transactions with prices ranging from $183.855 to $186.312.
The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 20, 2025.
Specifically, Cannon-Brookes sold 2,551 shares at a weighted average price of $184.7348, 1,149 shares at a weighted average price of $183.855, 250 shares at a weighted average price of $186.312, and 3,715 shares at a weighted average price of $185.5927.
Following these transactions, Cannon-Brookes indirectly owns 298,935 shares of Atlassian Corp through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
In other recent news, Moody’s Ratings has upgraded Atlassian Corporation’s senior unsecured notes from Baa3 to Baa2, while maintaining a stable outlook. This upgrade reflects expectations of rapid improvements in Atlassian’s credit profile and strong business execution. Moody’s predicts that Atlassian’s revenue will grow by 20% or more over the next 12 to 24 months, driven by an increase in cloud subscription revenues. Furthermore, Atlassian’s operating profit growth is expected to outpace its revenue growth during this period.
Meanwhile, Capital One (NYSE:COF) has downgraded Atlassian’s stock from Overweight to Equal-weight, citing concerns about fundamental challenges and valuation multiple compression. The firm’s new price target for Atlassian is set at $211.00, down from $241.00. On the other hand, Bernstein SocGen Group has reiterated an Outperform rating for Atlassian, maintaining a price target of $310.00. Bernstein’s analysis comes amid significant investor debate, with many viewing the stock as attractively priced despite existing concerns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.